Skip to content
Screener

Citius Pharmaceuticals CTXR Q4 2025 Annual earnings

Reported February 13, 2026 · After market close

Revenue$3.9MMiss by $14.1M
EPS-$0.38Miss by $0.81
Revenue estimate$18.0M
EPS estimate$0.43

Next report

Date not yet announced

FAQ

When did Citius Pharmaceuticals report Q4 2025 earnings?
Citius Pharmaceuticals (CTXR) reported Q4 2025 earnings on February 13, 2026 after market close.
What were Citius Pharmaceuticals's Q4 2025 revenue and EPS?
Citius Pharmaceuticals reported revenue of $3.9M and eps of $-0.38 for Q4 2025.
Did Citius Pharmaceuticals beat estimates in Q4 2025?
Revenue missed the consensus estimate of $18.0M by $14.1M. EPS missed the consensus estimate of $0.43 by $0.81.
How did Citius Pharmaceuticals's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 70.8% from $-1.30.
Where can I find Citius Pharmaceuticals's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001213900-26-015895) and the 10-K/A periodic report (0001213900-26-008861) directly on SEC EDGAR. The filing index links above go to sec.gov.